Results 211 to 220 of about 141,167 (306)
Comprehensive bioinformatics analysis of NCAPH expression and its clinical importance in endometrial cancer. [PDF]
Huang Y +6 more
europepmc +1 more source
ABSTRACT Background Hormone Replacement Therapy (HRT) is used to manage menopausal symptoms, particularly vasomotor symptoms (VMS). HRT prescribing rates are rising, but most women will eventually discontinue. Objectives To explore the experiences of women stopping HRT, why women restart HRT, and the HCPs advising them. Search Strategy Embase, MEDLINE,
Sarah Bunnewell +4 more
wiley +1 more source
Perceived Discrimination and Healthcare System Trust as Barriers to Survivorship Care in Endometrial Cancer. [PDF]
Brown JA +11 more
europepmc +1 more source
Risk of Cancer With Hormone Replacement Therapy: A Narrative Review
ABSTRACT Hormone replacement therapy (HRT) remains the cornerstone of menopausal symptom management, effectively alleviating vasomotor symptoms and genitourinary syndrome, whilst mitigating long‐term risks such as osteoporosis. However, despite an increasing body of evidence on the relative safety of HRT, earlier studies that demonstrated an increased ...
Gabriella Yongue +3 more
wiley +1 more source
Endometriosis and Endometrial Cancer-Association Between Biological Mechanisms and Its Clinical Implications. [PDF]
Marczuk KM +3 more
europepmc +1 more source
Reproductive Challenges of the Ageing Female: A Comprehensive Narrative Review
ABSTRACT Changes in societal norms over the last few decades have resulted in novel family planning trends, notably delayed childbearing and increased maternal age at the birth of the first child. Despite advances in reproductive medicine, ageing poses significant challenges.
Sofia Bitzika +6 more
wiley +1 more source
The expression and mechanism of action of ADAMTS18 in endometrial cancer. [PDF]
Li X, Xu M, Guo X, Xu Y.
europepmc +1 more source
ABSTRACT Background Elinzanetant, a novel, dual neurokinin‐targeted therapy, has been approved in various geographies for the treatment of moderate‐to‐severe vasomotor symptoms (VMS) associated with menopause. Objective To compare the efficacy of elinzanetant with non‐hormonal pharmaceutical treatments (nHT) in alleviating VMS.
Piotr Wojciechowski +8 more
wiley +1 more source

